Medicare drug coverage costs more this year

Most seniors in Medicare's prescription-drug program are paying considerably higher monthly premiums this year, according to a new study; we'll have to wait and see whether the higher costs force seniors to drop coverage--and in turn, some of their prescription drugs. Report

Suggested Articles

J&J's talc woes deepened Friday after the FDA turned up "sub-trace" levels of asbestos one bottle of the company's baby powder,…

Another major drugmaker is recalling in the U.K. 10 batches of its Zantac generics because they contain a possible carcinogen.

With diagnosis rates on the rise, Pfizer's Vyndaqel franchise could collect $157 million in 2019 U.S. sales, well above consensus, SVB Leerink says.